Raw materials in cell therapy

Raw materials are among the most critical, and often underestimated, factors influencing the success of a cell therapy program. Decisions made during early development can have far-reaching consequences for manufacturing scalability, process robustness, regulatory compliance, cost of goods, and ultimately patient access.

This interactive expert workshop provides a practical and strategic perspective on raw material qualification, supplier management, scalability, GMP transition, risk assessment, and long-term manufacturing readiness in cell therapy development.

Rather than focusing solely on regulatory requirements, the workshop explores the broader mindset behind raw material decision-making and how these choices influence the entire product lifecycle. Drawing on extensive industry experience, participants gain insight into common development challenges and learn practical approaches to identifying and mitigating potential technical, manufacturing, and regulatory bottlenecks before they arise.

Topics covered include:
• Raw material selection and qualification strategies
• Supplier qualification and management
• Scalability considerations and future manufacturing requirements
• GMP transition planning
• Risk assessment and mitigation strategies
• Change management and supply continuity
• Regulatory expectations and future readiness

The workshop is discussion-driven and incorporates real-world examples from cell therapy development to bridge the gap between theory and implementation.

Available as Corporate Training
This workshop is available as a customized training session for biotechnology companies, pharmaceutical organizations, CDMOs, academic groups, incubators, and innovation hubs.Sessions can be tailored to specific technologies, development stages, organizational needs, and team sizes.

Workshop Facilitators
This workshop is delivered by experienced cell therapy professionals with extensive expertise in raw material strategy, qualification, supplier management, CMC development, GMP manufacturing, and ATMP product development.Drawing on years of hands-on experience across biotechnology, pharmaceutical, and advanced therapy programs, the workshop combines practical industry perspectives with real-world examples to help participants understand how raw material decisions influence manufacturing scalability, regulatory readiness, quality systems, and long-term product success.Workshop facilitators are selected based on their expertise and experience in the specific topics covered and may vary between sessions.

Certificate of Participation
Participants receive a Certificate of Participation issued by Nordic Cell Therapy Group upon completion of the workshop.

Interested in Hosting This Workshop?
Contact Nordic Cell Therapy Group to discuss customized delivery options for your organization or team.




‍